Charles River Laboratories International, Inc. (CRL)
278.31
+5.31
(+1.95%)
USD |
NYSE |
Sep 11, 16:00
278.31
0.00 (0.00%)
After-Hours: 17:27
Charles River Laboratories International Gross Profit (TTM) : 1.305B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.305B |
| March 31, 2026 | 1.258B |
| December 31, 2025 | 1.226B |
| September 30, 2025 | 1.196B |
| June 30, 2025 | 1.207B |
| March 31, 2025 | 1.224B |
| December 31, 2024 | 1.269B |
| September 30, 2024 | 1.328B |
| June 30, 2024 | 1.334B |
| March 31, 2024 | 1.363B |
| December 31, 2023 | 1.386B |
| September 30, 2023 | 1.413B |
| June 30, 2023 | 1.405B |
| March 31, 2023 | 1.359B |
| December 31, 2022 | 1.314B |
| September 30, 2022 | 1.268B |
| June 30, 2022 | 1.238B |
| March 31, 2022 | 1.229B |
| December 31, 2021 | 1.210B |
| September 30, 2021 | 1.165B |
| June 30, 2021 | 1.122B |
| March 31, 2021 | 1.020B |
| December 31, 2020 | 964.72M |
| September 30, 2020 | 933.52M |
| June 30, 2020 | 894.28M |
| Date | Value |
|---|---|
| March 31, 2020 | 902.82M |
| December 31, 2019 | 871.31M |
| September 30, 2019 | 837.89M |
| June 30, 2019 | 812.07M |
| March 31, 2019 | 792.57M |
| December 31, 2018 | 771.05M |
| September 30, 2018 | 715.76M |
| June 30, 2018 | 684.08M |
| March 31, 2018 | 661.61M |
| December 31, 2017 | 652.59M |
| September 30, 2017 | 664.61M |
| June 30, 2017 | 642.60M |
| March 31, 2017 | 625.40M |
| December 31, 2016 | 596.54M |
| September 30, 2016 | 563.64M |
| June 30, 2016 | 551.02M |
| March 31, 2016 | 520.03M |
| December 31, 2015 | 500.12M |
| September 30, 2015 | 481.30M |
| June 30, 2015 | 462.50M |
| March 31, 2015 | 456.92M |
| December 31, 2014 | 450.04M |
| September 30, 2014 | 428.75M |
| June 30, 2014 | 413.95M |
| March 31, 2014 | 392.49M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| IQVIA Holdings, Inc. | 4.42B |
| Medpace Holdings, Inc. | 772.42M |
| Fortrea Holdings, Inc. | 438.30M |
| Avantor, Inc. | 2.012B |
| Champions Oncology, Inc. | 28.93M |